Financing, Equity Capital Markets

Mirati Therapeutics, Inc.

10/20
|
$1.0 Billion
Piper Sandler served as bookrunner for Mirati Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma